A detailed history of Jpmorgan Chase & CO transactions in Vaneck ETF Tr Vaneck Pharmaceu stock. As of the latest transaction made, Jpmorgan Chase & CO holds 155,563 shares of PPH stock, worth $14.8 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
155,563
Previous 106,512 46.05%
Holding current value
$14.8 Million
Previous $9.66 Million 47.31%
% of portfolio
0.0%
Previous 0.0%

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024

BUY
$84.87 - $93.23 $4.16 Million - $4.57 Million
49,051 Added 46.05%
155,563 $14.2 Million
Q1 2024

May 10, 2024

SELL
$82.63 - $90.89 $4.27 Million - $4.69 Million
-51,626 Reduced 32.65%
106,512 $9.66 Million
Q4 2023

Feb 12, 2024

SELL
$74.32 - $81.37 $3.35 Million - $3.67 Million
-45,051 Reduced 22.17%
158,138 $12.9 Million
Q3 2023

Nov 14, 2023

BUY
$76.26 - $83.18 $11.5 Million - $12.5 Million
150,365 Added 284.65%
203,189 $16.2 Million
Q2 2023

Aug 11, 2023

BUY
$75.02 - $80.55 $130,459 - $140,076
1,739 Added 3.4%
52,824 $4.16 Million
Q1 2023

May 11, 2023

BUY
$73.68 - $79.63 $3.72 Million - $4.02 Million
50,497 Added 8587.93%
51,085 $3.97 Million
Q4 2022

Feb 13, 2023

BUY
$67.31 - $79.26 $39,578 - $46,604
588 New
588 $46,000

Others Institutions Holding PPH

About VANECK ETF TR VANECK PHARMACEU


  • Ticker PPH
  • Sector ETFs
  • Industry ETFs
More about PPH
Track This Portfolio

Track Jpmorgan Chase & CO Portfolio

Follow Jpmorgan Chase & CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.